Li, Jiexi http://orcid.org/0000-0003-1508-5732
Lan, Zhengdao
Liao, Wenting
Horner, James W.
Xu, Xueping
Liu, Jielin
Yoshihama, Yohei
Jiang, Shan
Shim, Hong Seok
Slotnik, Max
LaBella, Kyle A. http://orcid.org/0000-0002-0473-9262
Wu, Chang-Jiun http://orcid.org/0000-0001-8350-6397
Dunner, Kenneth Jr.
Hsu, Wen-Hao
Lee, Rumi
Khanduri, Isha
Terranova, Christopher http://orcid.org/0000-0002-3674-7013
Akdemir, Kadir
Chakravarti, Deepavali
Shang, Xiaoying
Spring, Denise J. http://orcid.org/0000-0002-4593-0901
Wang, Y. Alan http://orcid.org/0000-0001-8272-2450
DePinho, Ronald A. http://orcid.org/0000-0002-5625-577X
Article History
Received: 18 October 2021
Accepted: 24 May 2023
First Online: 21 June 2023
Competing interests
: R.A.D. holds equity as a former advisor and/or director of Tvardi Therapeutics, Asylia Therapeutics, Stellanova Therapeutics and Sporos Bioventures. The remaining authors declare no competing interests.